Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome
Open Access
- 20 March 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (12) , 1864-1869
Abstract
Key Points: Increased levels of sCD19 protein in the CSF are associated with CNS disease in DLBCL and BL patients at risk of CNS lymphoma. Presence of lymphoma cells by FCM and/or increased CSF sCD19 levels are related with a poorer EFS and/or OS in DLBCL and BL patients.Keywords
This publication has 24 references indexed in Scilit:
- Clinical significance of occult cerebrospinal fluid involvement assessed by flow cytometry in non‐Hodgkin’s lymphoma patients at high risk of central nervous system disease in the rituximab eraEuropean Journal of Haematology, 2010
- Human peripheral blood B‐cell compartments: A crossroad in B‐cell trafficCytometry Part B: Clinical Cytometry, 2010
- Identification of Leptomeningeal Disease in Aggressive B-Cell Non-Hodgkin's Lymphoma: Improved Sensitivity of Flow CytometryJournal of Clinical Oncology, 2009
- Flow Cytometric Immunophenotyping of Cerebrospinal FluidCurrent Protocols in Cytometry, 2008
- Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patientsBlood, 2008
- Protein Biomarker Identification in the CSF of Patients With CNS LymphomaJournal of Clinical Oncology, 2008
- Secondary lymphomas of the central nervous system: risk, prophylaxis and treatmentLeukemia & Lymphoma, 2008
- Role of CD21 antigen in diffuse large B‐cell lymphoma and its clinical significanceBritish Journal of Haematology, 2004
- Three or more routes for leukocyte migration into the central nervous systemNature Reviews Immunology, 2003
- Expression of differentiation and adhesion molecules in sporadic Burkitt's lymphomaHematological Oncology, 1990